Oncology Therapeutics
Artificial Intelligence
Health Care
As featured in
Claim pageClaim
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
News
Lantern Pharma (LTRN) Q2 2026 Earnings Call Transcript
LP-300 shows strong efficacy in lung cancer while operating losses shrink 25%.
Read more
Report
Lantern Pharma Reports HARMONIC Data Showing LP-300 Progression-Free Survival Benefit Deepens with Treatment Duration in EGFR Exon 21 L858R Lung Cancer
Read more
Report
How Technologies Like AI and Machine Learning Can Help With the Development of Medicine
Lantern Pharma CEO Panna Sharma discusses how technologies like AI and machine learning can help with the development of medicine, manage treatment, and control costs.
Read more
Report
Lantern receives FDA clearance for paediatric STAR-001 CNS trial
Starlight Therapeutics subsidiary Lantern Pharma has secured FDA clearance for its IND application to initiate a Phase I paediatric CNS cancer trial of STAR-001.
Read more
Report
Report
Lantern Pharma Advancing LP-184 in Biomarker-Defined Breast, Lung, Bladder Cancers
Signals from a Phase Ia trial of LP-184 in solid tumors suggested that patients with DNA damage response gene mutations might respond well to the drug.
Read more
Report
Lantern Pharma's LP-184 Phase 1a Clinical Trial Achieves All Primary Endpoints with Robust Safety Profile and Promising Antitumor Activity in Multiple Advanced Solid Tumors
Read more
Report
Report
Lantern Pharma Unveils Groundbreaking AI-Powered Module to Predict Activity and Efficacy of Combination Regimens in Clinical Cancer Treatment
Lantern Pharma Inc, a pioneering artificial intelligence (AI) company transforming oncology drug discovery and development, today announced the launch of an innovative AI-powered module within its proprietary RADR platform
Read more
Report
Show more news
People

Panna Sharma
Executive Officer, Director

David Margrave
Executive Officer

Kishor Bhatia
Executive Officer

David Silberstein
Director

John Fucci
Director

Arunkumar Asaithambi
Director

Donald Keyser
Director

Lee Schalop
Director

Vijay Chandru
Director

Maria Maccecchini
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
3
Hiring now
0
Countries
1
Loading the map
Headquarters
Builds here
Office with open vacancies
No open vacancies right now Tap a pin for the office
Dallas
United States
HQ
Dallas HQ
1920 McKinney Ave. 7th Floor, Dallas, TX 75201
Atlanta
United States
Regional office
Atlanta Office
1175 Peachtree St. NE, Suite 1000, Office 10-124
Plano
United States
Regional office
Plano Office
7700 Windrose Ave.
